Radicava Now Approved Website

Brand: Radicava (edaravone), Intravenous Infusion
Parent Company: MT Pharma America
Drug Type: Prescription
Drug Category: Rheumatology
Campaign: now-approved
Targeting: Patients
Patient Website: https://www.radicava.com/patient/
HCP Website: https://www.radicava.com/hcp/